Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease.
Bezzio C, Franchellucci G, Savarino EV, Mastronardi M, Caprioli FA, Bodini G, Variola A, Scaldaferri F, Furfaro F, Calabrese E, Principi MB, Biscaglia G, Marzo M, Michielan A, Cavalli C, Aratari A, Campigotto M, Ceccarelli L, Cappello M, Saibeni S, Balestrieri P, Soriano A, Casini V, Bertani L, Barberio B, Conforti FS, Danese S, Armuzzi A. Bezzio C, et al. Among authors: barberio b. Crohns Colitis 360. 2024 Oct 24;6(4):otae060. doi: 10.1093/crocol/otae060. eCollection 2024 Oct. Crohns Colitis 360. 2024. PMID: 39525291 Free PMC article. No abstract available.
Upper gastrointestinal Crohn's disease: What are we talking about?
Bertin L, Barberio B, Savarino EV. Bertin L, et al. Among authors: barberio b. United European Gastroenterol J. 2024 Nov 7. doi: 10.1002/ueg2.12664. Online ahead of print. United European Gastroenterol J. 2024. PMID: 39508321 Free article. No abstract available.
Oral administration of Lactobacillus casei DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis -MEP1).
Angriman I, Scarpa M, Savarino E, Patuzzi I, Rigo A, Kotsafti A, Stepanyan A, Sciuto E, Celotto F, Negro S, Caruso A, Ruffolo C, Bardini R, Pucciarelli S, Barberio B, Spolverato G, Zingone F, D'Incà R, Castagliuolo I, Scarpa M. Angriman I, et al. Among authors: barberio b. Gut Microbes. 2024 Jan-Dec;16(1):2423037. doi: 10.1080/19490976.2024.2423037. Epub 2024 Nov 1. Gut Microbes. 2024. PMID: 39485259 Free PMC article. Clinical Trial.
Refractory Crohn's Disease: Perspectives, Unmet Needs and Innovations.
Bertin L, Crepaldi M, Zanconato M, Lorenzon G, Maniero D, De Barba C, Bonazzi E, Facchin S, Scarpa M, Ruffolo C, Angriman I, Buda A, Zingone F, Savarino EV, Barberio B. Bertin L, et al. Among authors: barberio b. Clin Exp Gastroenterol. 2024 Oct 10;17:261-315. doi: 10.2147/CEG.S434014. eCollection 2024. Clin Exp Gastroenterol. 2024. PMID: 39403342 Free PMC article. Review.
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium.
Lenti MV, Ribaldone DG, Borrelli de Andreis F, Vernero M, Barberio B, De Ruvo M, Savarino EV, Kav T, Blesl A, Franzoi M, Gröchenig HP, Pugliese D, Ianiro G, Porcari S, Cammarota G, Gasbarrini A, Spagnuolo R, Ellul P, Foteinogiannopoulou K, Koutroubakis I, Argyriou K, Cappello M, Jauregui-Amezaga A, Demarzo MG, Silvestris N, Armuzzi A, Sottotetti F, Bertani L, Festa S, Eder P, Pedrazzoli P, Lasagna A, Vanoli A, Gambini G, Santacroce G, Rossi CM, Delliponti M, Klersy C, Corazza GR, Di Sabatino A; European Consortium for the study of immune checkpoint inhibitor-induced colitis. Lenti MV, et al. Among authors: barberio b. ESMO Open. 2024 Jul;9(7):103632. doi: 10.1016/j.esmoop.2024.103632. Epub 2024 Jul 5. ESMO Open. 2024. PMID: 38970840 Free PMC article.
110 results